Intuitive Surgical (ISRG) news
Recent news
Synektik - Value of active offers as of Sept 30, 2026 estimated at PLN 200.1 mln
As of September 30, 2026, Synektik Spólka Akcyjna reported that the value of active offers stood at approximately PLN 200.1 million, reflecting ongoing demand for its medical equipment and services. The company has secured a series of contracts for the delivery of da Vinci robotic surgery systems…
AInvest Wire · 21h agoIntuitive Surgical, Inc.: BTIG cuts target price to $454 from $469
BTIG, a financial services firm, has revised its target price for Intuitive Surgical, Inc. (ISRG) to $454 from a previous estimate of $469, reflecting a slight downward adjustment in its valuation outlook for the medical technology company. This change comes amid ongoing analyst coverage of the…
AInvest Wire · 2d agoIntuitive announces expanded indication for Da Vinci SP in Europe
Intuitive Surgical has announced the expansion of the da Vinci SP System’s indications in Europe, broadening the range of procedures for which the single-port robotic platform can be used. This update reflects the system’s growing acceptance among surgeons and healthcare providers for its precision…
AInvest Wire · Sep 14, 2026Intuitive Surgical exec says planned 2027 extended-use instrument program could provide a tailwind to procedure growth as investors weigh slowing U.S. growth - Conf call
Intuitive Surgical (Nasdaq: ISRG) reported strong first-quarter financial results for 2026, with revenue rising 23% year-over-year to $2.77 billion, driven by increased procedure volumes and system placements. The company placed 431 da Vinci surgical systems during the quarter, including 232 da…
AInvest Wire · Sep 9, 2026Intuitive Surgical exec says co's growth drivers are expected to remain broadly consistent in 2026 compared with the prior year - Conf call
Intuitive Surgical (Nasdaq: ISRG) reported strong first-quarter financial results for 2026, with revenue rising 23% year over year to $2.77 billion, driven by increased procedure volumes and system placements. The company’s da Vinci surgical systems continued to lead growth, with 431 systems placed…
AInvest Wire · Sep 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.